Literature DB >> 8855827

The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen.

S R Plymate1, M Tennant, R S Birnbaum, J B Thrasher, G Chatta, J L Ware.   

Abstract

The insulin-like growth factor (IGF) system has been demonstrated to be important for proliferation and differentiation in tissues. This system has also been demonstrated to be an important regulator of the growth of normal prostate epithelium and has been implicated in the process of transformation to human epithelial prostate cancer. This study examined the function of the various components of the IGF system in benign prostate epithelium (BPE), simian virus-40 (SV40)-T antigen-immortalized prostate epithelial cells, P69SV40-T (P69), and two sublines generated from the parental line by serial passage through athymic mice: one tumorigenic (M2182) and one metastatic (M12). IGF-II messenger ribonucleic acid (mRNA) and protein were detected in BPE cells, and each of the three P69 cell lines. IGF-II protein levels were significantly higher in medium collected from the P69, M2182, and M12 cells than in BPE. Proliferation in response to IGF was P69 > BPE > M2182 > M12. The proliferative responses in the four cell types were paralleled by an increase in c-jun. In addition, as the cells became progressively more tumorigenic, the basal level of c-jun mRNA increased. IGF-binding protein-2 (IGFBP-2), -3, -4, -5, and -6 could be detected in the primary epithelial cell medium; however, as the cells became progressively more tumorigenic, there was a decrease in IGFBP-2, -3, -5, and -6 in the medium. The type 1 IGF receptor (IGFr) also decreased as the cells became more tumorigenic. The M12 cells had 80% fewer receptors than the P69 cells and 70% fewer than M2182 cells. There was no change in the Kd for IGF between the cell lines. Based on these data it would appear that the difference in proliferation between the BPE cells and P69s may be due to an increased concentration of inhibitory IGFBPs in the P69 medium. The decrease in proliferation seen in response to IGF in M2182 and M12 cells compared to the P69s would appear at least in part to be due to a decreased IGFr number. IGFr mRNA is represented by 11.0- and 7.0-kilobase bands in the BPE and P69 cells, but only by an 11.0-kilobase band in M2182 and M12 cells. These data indicate that there are significant changes that occur in the IGF system during the process of malignant transformation of the prostate epithelium. The changes described in the P69 cell system are similar to those seen in vivo and suggest that an intact IGF system may be important in maintaining a differentiated epithelial cell.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855827     DOI: 10.1210/jcem.81.10.8855827

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer.

Authors:  Hira Lal Goel; Cheng Chang; Bryan Pursell; Irwin Leav; Stephen Lyle; Hualin Simon Xi; Chung-Cheng Hsieh; Helty Adisetiyo; Pradip Roy-Burman; Ilsa M Coleman; Peter S Nelson; Robert L Vessella; Roger J Davis; Stephen R Plymate; Arthur M Mercurio
Journal:  Cancer Discov       Date:  2012-07-09       Impact factor: 39.397

2.  Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

Authors:  Shihua Sun; Cynthia C T Sprenger; Robert L Vessella; Kathleen Haugk; Kathryn Soriano; Elahe A Mostaghel; Stephanie T Page; Ilsa M Coleman; Holly M Nguyen; Huiying Sun; Peter S Nelson; Stephen R Plymate
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

3.  Type-1 insulin-like growth factor receptor reexpression in the malignant phenotype of SV40-T-immortalized human prostate epithelial cells enhances apoptosis.

Authors:  S S Plymate; V L Bae; L Maddison; L S Quinn; J L Ware
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

4.  Transforming Growth Factor-{beta}-Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor Inhibition.

Authors:  Cynthia C T Sprenger; Kathleen Haugk; Shihua Sun; Ilsa Coleman; Peter S Nelson; Robert L Vessella; Dale L Ludwig; Jennifer D Wu; Stephen R Plymate
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

Review 5.  Growth hormone and prostate cancer: guilty by association?

Authors:  A Grimberg; P Cohen
Journal:  J Endocrinol Invest       Date:  1999       Impact factor: 4.256

6.  Prostate cancer: serum and tissue markers.

Authors:  G J Miller; M K Brawer; W A Sakr; J B Thrasher; R Townsend
Journal:  Rev Urol       Date:  2001

7.  Interleukin-driven insulin-like growth factor promotes prostatic inflammatory hyperplasia.

Authors:  Alana M Hahn; Jason D Myers; Eliza K McFarland; Sanghee Lee; Travis J Jerde
Journal:  J Pharmacol Exp Ther       Date:  2014-10-07       Impact factor: 4.030

8.  Detection of a novel truncated WT1 transcript in human neoplasia.

Authors:  C Dechsukhum; J L Ware; A Ferreira-Gonzalez; D S Wilkinson; C T Garrett
Journal:  Mol Diagn       Date:  2000-06

9.  Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness.

Authors:  Ann-Christin Sandberg Nordqvist; Tiit Mathiesen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

10.  Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip.

Authors:  Shilpi Arora; Yipeng Wang; Zhenyu Jia; Saynur Vardar-Sengul; Ayla Munawar; Kutbuddin S Doctor; Michael Birrer; Michael McClelland; Eileen Adamson; Dan Mercola
Journal:  Genome Biol       Date:  2008-11-25       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.